• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY ORTHOPAEDICS INC US UNK KNEE FEMORAL LCS; FEMORAL 

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY ORTHOPAEDICS INC US UNK KNEE FEMORAL LCS; FEMORAL  Back to Search Results
Catalog Number UNK KNEE FEMORAL LCS
Device Problem Loss of or Failure to Bond (1068)
Patient Problems Foreign Body Reaction (1868); Hypersensitivity/Allergic reaction (1907); Pain (1994); Synovitis (2094); Metal Related Pathology (4530)
Event Date 01/01/2024
Event Type  Injury  
Event Description
This complaint is from a literature source.The following literature cite has been reviewed: sheridan ga, neufeld me, sidhu a, kurmis ap, kelly m, o'byrne jm, howard lc, masri ba, garbuz ds.The diagnostic utility of serum metal ion markers for high-grade aseptic lymphocyte-dominated vasculitis-associated lesions (alvals) in revision hip and knee arthroplasty: an international multicenter study.J arthroplasty.2024 jan;39(1):206-210.Doi: 10.1016/j.Arth.2023.06.024.Epub 2023 jun 16.Pmid: 37331438.Objective and methods: aseptic lymphocyte-dominated vasculitis-associated lesions (alvals) are typically described in the context of metal-on-metal (mom) hip bearings.This study explores the diagnostic utility of preoperative serum cobalt and chromium ion levels in determining the histological grade of alval in revision hip and knee arthroplasty.This was a multicenter retrospective review of 26 hips and 13 knees assessing the correlation between preoperative ion levels (mg/l (ppb)) and the histological grade of alval from intraoperative specimens.All metal ion levels were recorded within 3 months of the revision surgery.The cobalt: chromium (co:cr) ratio was also calculated based on these levels.All revision surgery was performed between january 1, 2011 and december 31, 2022.All revision procedures were performed at varying time intervals from the index procedure in hospitals located in canada, australia, and dublin, ireland.The article does not specify which revisions occurred in each country of event.Results: the depuy products revised in the study included 9 asr hip resurfacing constructs (head and cup), 1 duraloc/corail tha construct (cup, head, liner, and stem), 2 lcs and 1 attune tkas (femoral, insert, tibial tray).There is no indication that the patellas were resurfaced and the manufacturer of the cement utilized in the tkas was not provided.The results for the competitor constructs will be excluded from this complaint.The indications for all tha revisions were symptomatic armd and for the tkas was aseptic loosening.Histologic samples taken from the revision procedures identified synovitis, metallosis, metal debris (hips only), and pseudotumor.Additionally, serum cobalt and chromium levels were confirmed to be elevated above 7 ppb.
 
Manufacturer Narrative
Product complaint # (b)(4).D4: the device catalog number is unknown; therefore, udi is unavailable.This report is being submitted pursuant to the provisions of 21 cfr, part 803 (and/or part 4, as applicable).This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes, or its employees that the report constitutes an admission that the product, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Manufacturer Narrative
Product complaint # (b)(4).Investigation summary : no device associated with this report was received for examination.An evaluation of the manufacturing record could not be performed as the required lot number was not provided to complete the evaluation.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.Additional complaint information monitoring for potential safety signals will be conducted through complaint trending as part of the post-market surveillance.If additional information is made available, the investigation will be updated as applicable.Device history lot : the device lot number is unknown, therefore a device history review could not be performed.If the lot/serial number becomes available, the record will be re-assessed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK KNEE FEMORAL LCS
Type of Device
FEMORAL 
Manufacturer (Section D)
DEPUY ORTHOPAEDICS INC US
700 orthopaedic drive
warsaw IN 46581 0988
Manufacturer (Section G)
JTE WARSAW MFG SITE
700 orthopaedic drive
warsaw IN
Manufacturer Contact
kate karberg
700 orthopaedic dr.
warsaw, IN 46581-0988
3035526892
MDR Report Key18885912
MDR Text Key337437639
Report Number1818910-2024-05591
Device Sequence Number1
Product Code JWH
Combination Product (y/n)N
Reporter Country CodeCA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 03/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK KNEE FEMORAL LCS
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 03/04/2024
Initial Date FDA Received03/12/2024
Supplement Dates Manufacturer Received03/26/2024
Supplement Dates FDA Received03/27/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-